102719-93-7 | Vobasan-17-oic acid,3-[3-(2-aminoethyl)-1H-indol-6-yl]-, methyl ester, (3a)- (9CI) | C31H36 N4 O2 |
102719-90-4 | (-)-N-(5a,6,7,8-Tetrahydro-4-methyl-1,5-dioxo-5H-pyrrolo[1,2-c][1,3]oxazepin-3-yl)hexanamide | C15H22 N2 O4 |
102719-98-2 | Aconitane-8,14-diol,20-ethyl-1,16-dimethoxy-4-methyl-, 14-acetate, (1a,14a,16b)- | C25H39 N O5 |
102719-85-7 | crebanine N-oxide | C20H21 N O5 |
102719-84-6 | 3-oxo-11-methoxytabersonine | C22H24 N2 O4 |
102719-89-1 | (-)-3-Methyl-N-[5a,6,7,8-tetrahydro-4-methyl-1,5-dioxo-5H-pyrrolo[1,2-c][1,3]oxazepin-3-yl]butanamide | C14H20 N2 O4 |
102719-88-0 | Carbamic acid,[2-[6-(1,3-dioxolo[4,5-h]isoquinolin-7-yl)-1,3-benzodioxol-5-yl]ethyl]methyl-,ethyl ester (9CI) | C23H22 N2 O6 |
102719-18-6 | 1,4:6,10-Diepoxy-1H-cycloheptcoxepin-5,9-dione, 3,4,5a,6,10,10a-hexahydro-, 1R-(1.alpha.,4.alpha.,5a.beta.,6.alpha.,10.alpha.,10a.beta.)- | C11H10 O5 |